$BORAY News
Last published 3mo ago
- 3mo agoBORAYBora Pharmaceuticals and Onconic Therapeutics Sign Manufacturing Agreement to Support U.S. Clinical Development of JAQBO TabletsBusiness WireBora to manufacture and package clinical trial drug product for JAQBO tablets as Onconic advances U.S. Phase 3 preparation for gastroesophageal reflux disease (GERD) Bora Pharmaceuticals Co., Ltd. (("Bora",
- 4mo agoMGNXBORAYMacroGenics Completes Sale of GMP Manufacturing Operations to Bora PharmaceuticalsGlobeNewswireROCKVILLE, MD, July 02, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer,
- 6mo agoBORAYMGNXMacroGenics to Sell GMP Manufacturing Operations to Bora PharmaceuticalsGlobeNewswire•MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO operations and associated personnel to Bora ROCKVILLE, MD, May 11, 2026 (GLOBE
- 8mo agoBORAYBora Pharmaceuticals to Present at the Life Sciences Investor Forum on March 12thGlobeNewswireTAIPEI, Taiwan, March 03, 2026 (GLOBE NEWSWIRE) -- Bora Pharmaceuticals (("Bora", TWSE: 6472, OTCQX:BORAY), based in [Taipei, Taiwan], a global leader in pharmaceutical manufacturing, today announced that Bobby Sheng,
- 8mo agoBORAYGSKBora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing ContractBusiness WireBora manufactures more than 20 commercial products for GSK at its Mississauga facility, supporting infectious disease, mental health, dermatology, & other critical therapeutic areas Bora Pharmaceuticals Co., Ltd.
- 10mo agoBORAYOTCMOTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQXGlobeNewswireNEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX:OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bora Pharmaceuticals Co., Ltd.